Back to Results
First PageMeta Content



Bridging the gap between validation and implementation of non-animal potency testing methods 3 Samantha Dozier, PhD, Policy Advisor, Nanotechnology and Medical Testing Issues;1 Jeffrey Brown, Research Associate;1 Alista
Add to Reading List

Document Date: 2013-04-12 12:08:25


Open Document

File Size: 386,74 KB

Share Result on Facebook

Country

United States / United Kingdom / /

/

Event

Product Issues / Product Recall / /

/

IndustryTerm

annual search / erysipelas vaccine products / lot release protocols / leptospirosis vaccine products / /

MedicalCondition

Leptospirosis / U.S.-licensed leptospirosis / U.S.-licensed erysipelas / catalogue Erysipelas / pertussis / erysipelas / Tetanus / Swine erysipelas / companies Pertussis / FOIA Yes Pertussis / inactivated swine erysipelas / /

Organization

United States Department of Agriculture / People for the Ethical Treatment of Animals / Veterinary Biologics European Directorate for the Quality of Medicines and HealthCare Enzyme-linked / FDA / Department of Agriculture Veterinary Medicines Directorate Contact / USDA / European Medicines Agency European Center for the Validation of Alternative Methods Scientific Advisory Committee FOIA HO PETA SAM SOP TABST USDA VMD / European Union / Animals Regulatory Testing Division / Federal Regulations Center / /

Person

Jeffrey Brown / AWA CFR CVB EDQM ELISA / ELISA EMEA ESAC / SAM SOP TABST USDA VMD / Nanotechnology / /

/

Position

author / Policy Advisor / Research Associate / /

Product

in vivo SAMs / /

ProvinceOrState

Virginia / /

Technology

lot release protocols / /

URL

http /